StreetAlpha
Petmed Express Inc · Earnings

PETS Earnings Results and History

Latest: Q2 FY2027From SEC 8-K, 10-Q and 10-K filingsNext report: Feb 9, 2027

Petmed Express Inc's earnings at a glance: the latest results and outlook from the press release, revenue, margins and EPS for every quarter from the company's SEC filings, and how the stock moved after each report. New results show here within about a minute of being filed.

← PETS stock page

Q2 FY2027 result
Results are out
  • EPS−$0.31 Members
  • Revenue$35.8M −19.4% vs a year ago

Filed ยท Press release

Revenue growth−19.4%vs −23.6% a year ago
Operating margin−17.9%vs −18.9% a year ago
Avg move afterMembersnext day, after each report

Key takeaways

from the press release
  • Net sales fell 19.4% to $35.8 million, driven by lower prescription medication sales and higher consumer promotional usage.
  • Net loss narrowed to $6.4 million, or $(0.31) per share, from $8.5 million a year earlier.
3 more takeaways with a free account.Create free account

EPS by quarter

GAAP diluted, 12 quarters
Dec 2023: EPS -$0.10-0.10Dec '23Mar 2024: EPS -$0.25-0.25Mar '24Jun 2024: EPS $0.180.18Jun '24Sep 2024: EPS $0.110.11Sep '24Dec 2024: EPS -$0.03-0.03Dec '24Mar 2025: EPS -$0.56-0.56Mar '25Jun 2025: EPS -$1.65-1.65Jun '25Sep 2025: EPS -$0.41-0.41Sep '25Dec 2025: EPS -$0.50-0.50Dec '25Mar 2026: EPS -$0.19-0.19Mar '26Jun 2026: EPS -$0.28-0.28Jun '26Sep 2026: EPS -$0.31-0.31Sep '26

Revenue and operating margin

from 10-Q and 10-K
Dec 2023: revenue $63.7M-5%Dec '23Mar 2024: revenue $65.1M-6%Mar '24Jun 2024: revenue $66.2M7%Jun '24Sep 2024: revenue $58M1%Sep '24Dec 2024: revenue $52M-1%Dec '24Mar 2025: revenue $50.8M-12%Mar '25Jun 2025: revenue $51.2M-67%Jun '25Sep 2025: revenue $44.4M-19%Sep '25Dec 2025: revenue $40.7M-26%Dec '25Mar 2026: revenue $42.8M-13%Mar '26Jun 2026: revenue $41M-15%Jun '26Sep 2026: revenue $35.8M-18%Sep '26
RevenueOperating margin %

Quarter by quarter

from 10-Q and 10-K filings
Quarter endedRevenueGrowthGross marginOp marginNet incomeEPSFree cash flow
Sep 2026$35.8M−19.4%27.4%−17.9%−$6.4M−$0.31−$1.6M
Jun 2026$41M−19.9%27.6%−15.2%−$6.1M−$0.28−$8.3M
Mar 2026$42.8M−15.6%32.6%−13.3%−$4.1M−$0.19−$5.5M
Dec 2025$40.7M−21.7%23.3%−25.7%−$10.6M−$0.50−$9.2M
Create a free account to see all 12 quarters, or sign in.Sign in to see all 12 quarters.

EPS here is GAAP diluted, as filed with the SEC. Estimates are usually based on adjusted EPS, so the two can differ. Growth compares with the same quarter a year earlier.

Reports and price reactions

last 2 reports
How PETS moved after each of its last 2 reports, beat or miss, the move options priced in, and StreetAlpha's call. For AI Starter and AI Pro members.See plans

Year by year

fiscal years, from 10-K filings
Year endedRevenueGrowthOp marginNet incomeEPS
Mar 31, 2026$179M−21.1%−32.8%−$57.3M−$2.74
Mar 31, 2025$227M−17.2%−0.7%−$6.3M−$0.30
Mar 31, 2024$274.1M+10.7%−3.0%−$7.5M−$0.37
Mar 31, 2023$247.6M−9.1%2.4%$5.1M$0.25
Mar 31, 2022$272.3M–8.9%$18.7M$0.92

Filings and dates

SEC EDGAR
  • Feb 9, 2027Next earnings reportafter the close
  • Nov 10, 2026Earnings release, Q2 FY20278-K Press release
  • Nov 10, 2026Quarterly report10-Q All filings

Also see PETS institutional ownership and the earnings calendar.

PETS earnings FAQ

What were PETS's latest earnings?

For Q2 FY2027 Petmed Express Inc reported revenue of $35.8M, GAAP EPS of -$0.31. The results were filed with the SEC on Nov 10, 2026.

When is PETS's next earnings date?

Petmed Express Inc is expected to report on Feb 9, 2027, after the market closes. Dates can move until the company confirms them.

Is PETS's revenue growing?

In the quarter ended Sep 30, 2026 revenue was $35.8M, down 19.4% from a year earlier. The table on this page shows every quarter from the company's 10-Q and 10-K filings.

Where do these numbers come from?

Results, guidance and financials come from Petmed Express Inc's own SEC filings: the earnings press release (Form 8-K) and the quarterly and annual reports (10-Q and 10-K). Key takeaways summarize the press release. Estimates and price moves come from market data.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Results come from company filings with the SEC. Estimates are consensus figures from before each report. Key takeaways summarize the company's press release and may contain errors; the press release is the authoritative source.